Zhengbin Yao

Title: Zhengbin Yao: Innovator in Antibody Research

Introduction

Zhengbin Yao is a prominent inventor based in Berwyn, PA (US), known for his significant contributions to the field of antibody research. He holds a total of 5 patents, showcasing his innovative approach to addressing critical health issues.

Latest Patents

Among his latest patents is the invention of antagonist anti-Notch3 antibodies and their use in the prevention and treatment of Notch3-related diseases. This invention focuses on antibodies that specifically bind to Notch 3, inhibiting its activation. The technology includes antibodies that target a conformational epitope comprising the first Lin12 domain and the second dimerization domain. Additionally, he has developed a patent for the diagnosis of malignant neoplasms using anti-Notch3 antibodies. This invention involves novel antibodies that specifically bind to human Notch 3, aiding in the detection and diagnosis of Notch 3 related diseases, including cancer. The patent also encompasses nucleic acids encoding these antibodies, vectors, cell lines harboring the nucleic acids, and kits for diagnostic use.

Career Highlights

Zhengbin Yao has worked with notable companies such as Genentech, Inc. and Aventisub II Inc., where he has applied his expertise in antibody development and research. His work has significantly impacted the field of medical diagnostics and therapeutics.

Collaborations

Throughout his career, Zhengbin has collaborated with esteemed colleagues, including Sek Chung Fung and Kang Li, contributing to various innovative projects in the biotechnology sector.

Conclusion

Zhengbin Yao's work in antibody research exemplifies the importance of innovation in addressing complex medical challenges. His patents and collaborations highlight his commitment to advancing healthcare solutions.